PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16175257

An integrated microfluidic processor for single nucleotide polymorphism-based DNA computing.

William H Grover·Richard A Mathies
View original source ↗Export metadata ↓

Abstract

An integrated microfluidic processor is developed that performs molecular computations using single nucleotide polymorphisms (SNPs) as binary bits. A complete population of fluorescein-labeled DNA "answers" is synthesized containing three distinct polymorphic bases; the identity of each base (A or T) is used to encode the value of a binary bit (TRUE or FALSE). Computation and readout occur by hybridization to complementary capture DNA oligonucleotides bound to magnetic beads in the microfluidic device. Beads are loaded into sixteen capture chambers in the processor and suspended in place by an external magnetic field. Integrated microfluidic valves and pumps circulate the input DNA population through the bead suspensions. In this example, a program consisting of a series of capture/rinse/release steps is executed and the DNA molecules remaining at the end of the computation provide the solution to a three-variable, four-clause Boolean satisfiability problem. The improved capture kinetics, transfer efficiency, and single-base specificity enabled by microfluidics make our processor well-suited for performing larger-scale DNA computations.

Explore related subjects

BiotinylationComputational BiologyDNAFluoresceinKineticsMicrofluidic Analytical TechniquesMicrofluidicsOligonucleotidesPolymorphism, Single NucleotideSoftwareTime FactorsJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

William H Grover, Richard A Mathies. 2005-08-11. An integrated microfluidic processor for single nucleotide polymorphism-based DNA computing.. https://doi.org/10.1039/b505840f

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

TYK2 activity promotes ligand-induced IFNAR1 proteolysis.

The type I IFNR (interferon receptor) is a heterodimer composed of two transmembrane chains, IFNAR1 (interferon-alpha receptor 1 subunit) and IFNAR2, which are associated with the tyrosine kinases Tyk2 and Jak1 (Janus kinase 1) respectively. Ligand-induced down-regulation of the type I IFNR is a major mechanism of negative regulation of cellular signalling and involves the internalization and lysosomal degradation of IFNAR1. IFNalpha promotes the phosphorylation of IFNAR1 on Ser535, followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 (beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis. The non-catalytic role of Tyk2 in sustaining the steady-state IFNAR1 level at the plasma membrane is well documented; however, little is known about the function of Tyk2 in the steps that precede and succeed serine phosphorylation and ubiquitination of IFNAR1 in response to ligand binding. In the present study, we show that catalytic activation of Tyk2 is not essential for IFNAR1 internalization, but is required for ligand-induced IFNAR1 serine phosphorylation, ubiquitination and efficient lysosomal proteolysis.

Biotinylation↗
PubMed2006

Rapid, reliable and inexpensive quality assessment of biotinylated cRNA.

The interpretation of oligonucleotide array experiments depends on the quality of the target cRNA used. cRNA target quality is assessed by quantitative analysis of the representation of 5' and 3' sequences of control genes using commercially available Test arrays. The Test array provides an economically priced means of determining the quality of labeled target prior to analysis on whole genome expression arrays. This manuscript validates the use of a duplex RT-PCR assay as a faster (6 h) and less expensive (<10 US dollars) but equally accurate alternative to the Test arrays in determining biotinylated cRNA quality. Forty-one different cRNA samples were hybridized to HG-U133A microarrays from Affymetrix. Ten cRNA samples with a beta-actin 3'/5' ratio >6 were chosen and classified as degraded cRNAs, and 31 samples with a beta-actin 3'/5' ratio <6 were selected as good quality cRNAs. Blinded samples were then used for the RT-PCR assay. After gel electrophoresis, optical densities of the amplified 3' and 5' fragments of beta-actin were measured and the 3'/5' ratio was calculated. There was a strong correlation (r(2) = 0.6802) between the array and the RT-PCR beta-actin 3'/5' ratios. Moreover, the RT-PCR 3'/5' ratio was significantly different (P < 0.0001) between undegraded (mean +/- SD, 0.34 +/- 0.09) and degraded (1.71 +/- 0.83) samples. None of the other parameters analyzed, such as i) the starting amount of RNA, ii) RNA quality assessed using the Bioanalyzer Chip technology, or iii) the concentration and OD260/OD280 ratio of the purified biotinylated cRNA, correlated with cRNA quality.

Biotinylation↗
PubMed2006

Silica-coated CdTe quantum dots functionalized with thiols for bioconjugation to IgG proteins.

Quantum dots (QDs) have been increasingly used in biolabeling recently as their advantages over molecular fluorophores have become clear. For bioapplications QDs must be water-soluble and buffer stable, making their synthesis challenging and time-consuming. A simple aqueous synthesis of silica-capped, highly fluorescent CdTe quantum dots has been developed. CdTe QDs are advantageous as the emission can be tuned to the near-infrared where tissue absorption is at a minimum, while the silica shell can prevent the leakage of toxic Cd(2+) and provide a surface for easy conjugation to biomolecules such as proteins. The presence of a silica shell of 2-5 nm in thickness has been confirmed by transmission electron microscopy and atomic force microscopy measurements. Photoluminescence studies show that the silica shell results in greatly increased photostability in Tris-borate-ethylenediaminetetraacetate and phosphate-buffered saline buffers. To further improve their biocompatibility, the silica-capped QDs have been functionalized with poly(ethylene glycol) and thiol-terminated biolinkers. Through the use of these linkers, antibody proteins were successfully conjugated as confirmed by agarose gel electrophoresis. Streptavidin-maleimide and biotinylated polystyrene microbeads confirmed the bioactivity and conjugation specificity of the thiolated QDs. These functionalized, silica-capped QDs are ideal labels, easily synthesized, robust, safe, and readily conjugated to biomolecules while maintaining bioactivity. They are potentially useful for a number of applications in biolabeling and imaging.

Biotinylation↗